Updated July 26 at 6:26pm
Biotechnology
69 results total, viewing 61 - 69
(Updated, 6:15 p.m.) Ventas Inc., a real estate investment trust with more than 1,300 properties, has announced its intention to purchase substantially all of the assets of Wexford Science & Technology LLC. more
Richard A. Andrews has been appointed chief operating officer at ProThera Biologics. more
Richard A. Andrews recently was appointed chief operating officer at ProThera Biologics in Providence, a company that is developing inter-alpha inhibitor proteins to treat severe inflammation associated with infection, trauma and disease. He discussed his new role at the company with Providence Business News, as well as his past experience. more
IlluminOss Medical Inc. said Monday that it has completed enrollment in its first U.S. clinical trial toward U.S. Food and Drug Administration approval of its IlluminOss System, a minimally invasive system to repair bone fractures. more
Alexion Pharmaceuticals Inc. this morning hosted a groundbreaking ceremony for an expansion that is expected to double the size of its plant over the next five years. more
(Updated, 5:40 p.m.) Ximedica announced Tuesday it has purchased the San Francisco-based Bridge Design, providing the Rhode Island-based medical technology development company with a West Coast hub. more
(Updated, 4 p.m., Aug. 21) Some of the region’s most notable companies have been named in Providence Business News’ fourth Fastest-Growing & Innovative Companies awards program. more
Medtronic PLC, the largest maker of equipment to treat spinal conditions, agreed to help promote Mazor Robotics Ltd.’s guidance system used during spinal surgeries and will take an equity stake of up to 15 percent in the company. Mazor’s stock surged. more
Dr. Barrett Bready is founder and CEO of Nabsys, a genomics firm. An adjunct professor at Brown University where he teaches biotechnology management, Bready also serves as a commissioner on the I-195 Redevelopment District Commission. Bready talked with Providence Business News about Nabsys’ evolution and goals for the future. more
« Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7